Vascular Grafts Market Size, Forecast, Analysis & Share Surpass US$ 3,000 Million | 2026, at 5.6% CAGR 

According to the report, the global 𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐠𝐫𝐚𝐟𝐭𝐬 market was valued at US$ 2,010.1 Mn in 2017 and is projected to expand at a CAGR of 5.0% from 2018 to 2026 to reach US$ 3,000 Mn by 2026. Increase in incidence of cardiovascular diseases and peripheral diseases is anticipated to boost the growth of the global market from 2018 to 2026. However, demand for vascular grafts is expected to decline during the forecast period owing to its adverse effects and stringent regulatory guidelines for new product approval. However, surge in government investment in health care infrastructure and strategic alliances among players to penetrate the emerging markets are likely to propel the global vascular grafts market during the forecast period. For instance, in April 2018, Terumo Corporation's Vascutek merged with Bolton Medical to form a single entity focused on the aortic and vascular implants market.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐚 𝐬𝐚𝐦𝐩𝐥𝐞 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐨𝐫𝐭 𝐚𝐭 (𝐔𝐬𝐞 𝐂𝐨𝐫𝐩𝐨𝐫𝐚𝐭𝐞 𝐌𝐚𝐢𝐥 𝐈𝐝 𝐟𝐨𝐫 𝐐𝐮𝐢𝐜𝐤 𝐑𝐞𝐬𝐩𝐨𝐧𝐬𝐞) - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=62916

𝐄𝐧𝐝𝐨𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐒𝐭𝐞𝐧𝐭 𝐆𝐫𝐚𝐟𝐭𝐬 𝐒𝐞𝐠𝐦𝐞𝐧𝐭 𝐭𝐨 𝐂𝐚𝐩𝐭𝐮𝐫𝐞 𝐋𝐚𝐫𝐠𝐞𝐬𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐡𝐚𝐫𝐞

The endovascular stent grafts segment accounted for the largest market share in 2017. The segment is anticipated to expand at a high CAGR during the forecast period, owing to increase in the number of coronary artery and CKD patients and vascular surgeons preferring graft- and stent- based surgeries. Moreover, endovascular stent graft therapy is a minimally surgical procedure and reduces the recovery time by several days.

𝐋𝐚𝐫𝐠𝐞 𝐒𝐢𝐳𝐞 𝐕𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐆𝐫𝐚𝐟𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭 𝐭𝐨 𝐀𝐜𝐜𝐨𝐮𝐧𝐭 𝐟𝐨𝐫 𝐋𝐚𝐫𝐠𝐞𝐬𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐡𝐚𝐫𝐞

In term of size of vascular graft, the large segment is projected to account for the largest market share during the forecast period owing to the wide usage of larger grafts of diameter above 6mm in the treatment of vascular diseases due to its high patency and flexibility.

𝐇𝐨𝐬𝐩𝐢𝐭𝐚𝐥𝐬 𝐒𝐞𝐠𝐦𝐞𝐧𝐭 𝐭𝐨 𝐀𝐜𝐜𝐨𝐮𝐧𝐭 𝐟𝐨𝐫 𝐒𝐢𝐠𝐧𝐢𝐟𝐢𝐜𝐚𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐡𝐚𝐫𝐞

The hospitals segment held the largest share of the global vascular grafts market in 2017. Rise in awareness about advantages of hospitals such as availability of advanced devices, all levels of treatment for different surgeries, and trained staff boosts the growth of the segment. Additionally, favorable reimbursement facilities provided by hospitals through different Medicare policies also increases patient preference for surgery in hospitals.

𝐁𝐮𝐲 𝐭𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 | 𝐈𝐦𝐦𝐞𝐝𝐢𝐚𝐭𝐞 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐲 𝐀𝐯𝐚𝐢𝐥𝐚𝐛𝐥𝐞 𝐚𝐭 - https://www.transparencymarketresearch.com/checkout.php?rep_id=62916<ype=S

𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚 𝐌𝐚𝐫𝐤𝐞𝐭 𝐭𝐨 𝐛𝐞 𝐝𝐫𝐢𝐯𝐞𝐧 𝐛𝐲 𝐑𝐢𝐬𝐞 𝐢𝐧 𝐕𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐒𝐮𝐫𝐠𝐞𝐫𝐢𝐞𝐬, 𝐞𝐬𝐩𝐞𝐜𝐢𝐚𝐥𝐥𝐲 𝐢𝐧 𝐔.𝐒.

North America held major share of the global vascular grafts market in 2017, supported by high cost of technologically advanced grafts and rise in prevalence of cardiovascular diseases. Moreover, increase in R&D activities for the development of small size vascular grafts to treat small vascular diseases augment the market in the region. According to the American Heart Association (2013), around 400,000 coronary artery bypass grafting (CABG) procedures are performed each year in the U.S. alone.

𝐋. 𝐆𝐨𝐫𝐞 & 𝐀𝐬𝐬𝐨𝐜𝐢𝐚𝐭𝐞𝐬, 𝐌𝐚𝐪𝐮𝐞𝐭 𝐇𝐨𝐥𝐝𝐢𝐧𝐠, 𝐚𝐧𝐝 𝐁𝐃 𝐃𝐨𝐦𝐢𝐧𝐚𝐭𝐞𝐝 𝐌𝐚𝐫𝐤𝐞𝐭

Key companies operating in the global vascular grafts market and profiled in the report include W. L. Gore & Associates, Inc., Maquet Holding B.V. & Co. KG (Getinge Group), BD, LeMaitre Vascular, Inc., B. Braun Melsungen AG, Cook Medical, Medtronic plc, Artegraft, Inc., Vascutek Ltd., Vascular Graft Solution Ltd., Heat Medical Europe BV, and CryoLife, Inc. Market players adopt strategies such as expansion of product portfolio by developing new products or through acquisitions and licensing agreements. For instance, in February 2016, Vascular Graft Solutions Ltd. received unconditional IDE approval from the U.S. FDA to initiate a study to support the future premarketing approval (PMA) application for the VEST external support for coronary bypass vein grafts.

𝐌𝐨𝐫𝐞 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐓𝐫𝐚𝐧𝐬𝐩𝐚𝐫𝐞𝐧𝐜𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 -

𝐈𝐧𝐬𝐮𝐥𝐢𝐧 𝐌𝐚𝐫𝐤𝐞𝐭- https://www.prnewswire.com/news-releases/insulin-market-to-exceed-us-30-bn-by-2031-global-burden-of-diabetes-and-complications-propelling-adoption-of-therapies-observes-tmr-report-301570945.html

𝐀𝐜𝐭𝐢𝐯𝐞 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐈𝐧𝐠𝐫𝐞𝐝𝐢𝐞𝐧𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭- https://www.prnewswire.com/news-releases/active-pharmaceutical-ingredients-api-market-to-reach-us-331-3-bn-by-2031-shift-to-in-house-manufacturing-of-api-expanding-avenue-finds-tmr-study-301548765.html

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬 𝐓𝐫𝐚𝐧𝐬𝐩𝐚𝐫𝐞𝐧𝐜𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬

Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.